Flu vaccine could be available soon to protect against several strains of deadly virus


A one-size-fits-all flu vaccine could be on the horizon after scientists found an antibody that protects against several strains of the virus.

The team from the University of Pittsburgh School of Medicine identified a class of antibodies previously unrecognised that can neutralise different forms of flu.

At the moment the most dominant strain is predicted and a vaccine produced to protect against it but the new breakthrough could see an end to that.

Antibodies are immune system proteins that protect against disease and a vaccine prompts the immune system to make them.

The antibodies bind to a viral protein called hemagglutinin on the outside of an invading flu virus, blocking it from entering a person’s cells.

READ MORE: James Martin’s horrific ‘heart attack’ experience was a wake-up call

But different antibodies bind to different parts of hemagglutinin which itself evolves over time, leading to new strains that outwit old antibodies.

Two flu subtypes known as H1 and H3 come in multiple strains and scientists have been focused on these to produce a universal vaccine.

The current study found that although some antibodies were effective against H1 and H3, they failed if the hemagglutinin is carrying what they call the 133a insertion.

The team, writing in the journal PLOS Biology, say they have found the new antibodies that can neutralise H1 and H3 whether they have the 133a insertion or not.

They carried out their experiments on blood taken from patients.

Lead author and research assistant Holly Simmons said: “We need annual influenza virus vaccines to keep pace with continuing viral evolution.

“Our work suggests that the barriers to eliciting more broadly protective immunity may be surprisingly low.

“Given the right series of influenza virus exposures/vaccinations, it is possible for humans to mount robust antibody responses that neutralise divergent H1N1 and H3N2 viruses, opening new avenues to design improved vaccines.”

“This research expands the list of antibodies that could potentially contribute to development of a flu virus that achieves broader protection through an assortment of molecular mechanisms.”

Follow our social media accounts here on facebook.com/ExpressUSNews and @expressusnews



Leave a Reply

Your email address will not be published.